The deadly disease of lung cancer takes about 1.76 million cancer deaths worldwide. The well-known risk factors behind lung cancer include tobacco intake, cigarette smoking, environmental exposure etc. A history of autoimmune…
Category: Lung Cancer Study
Study: Mouth Bacteria May Develop Lung Cancer Among Non-Smokers
Although cigarette smoking remains the major cause of lung cancer, but those who have never smoked a cigarette in their lives can also develop this disease. Non-smokers make up around 1/4th of…
Study Shows Women Have Lower Risk of Death after Lung Cancer Surgery
The survival rates among men and women with lung cancer vary. Researchers at Karolinska Institutet in Sweden have conducted a study to find out the potential reasons behind these differences such as…
NEJM Study Found Sotorasib to be Effective in Non-Small Cell Lung Cancer
The researchers at New England Journal of Medicine have found Sotorasib to be safe having clinical benefit in non-small cell lung cancer (NSCLC). The results of the study were presented at the…
New Study Identifies Drug to Boost Lung Cancer Survival Rates
A new study has found that a newly approved drug for leading form of cancer, lung cancer works to improve patient survival rate. The immunotherapy drug is called Tecentriq or atezolizumab. It…
Korean Study Examined Three-Drug Combo to Reduce Lung Cancer Risk
The combined use of aspirin, statins and metformin is associated with reduced risk of lung cancer, according to a study published in the Journal of Thoracic Oncology. The purpose behind the study…
Study: Nicotine May Promote Brain Tumors in Lung Cancer Patients
According to a new study, researchers have found that nicotine actually promotes the spread of lung cancer cells into the brain where they can form deadly metastatic tumors. Nicotine is a non-carcinogenic…
Yale Cancer Center Study Shows Long-Term Survival Benefits for Lung Cancer Patients
As per the global study led by Yale Cancer Center, a tiny amount of biomarker known as PD-L1 can predict long-term survival benefits from pembrolizumab. Pembrolizumab (Keytruda) is one of the first…